Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$17.84M
283.19K shares
What this filing means
HEERMA PETER plans to sell 283.19K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $17.84M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/17/2026ACC: 0001950047-26-009625
Officer· Chief Commercial Officer
Since Oct 2019
283.19K
Shares to sell
$17.84M
Approx. market value
8.28K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/17/2026
8.28KTotal acquired8.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2026 | Exercise of Stock Options Cash | 8.28K | — |
| Total | 8.28K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
172.72K
Market value
$10.96M
9/16/2026
—Completed
Units to sell
102.19K
Market value
$6.36M
9/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.28K
Market value
$525.7K
9/17/2026
Total
Units
283.19K
Value
$17.84M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 172.72K | $10.96M | — | Completed |
9/15/2026 | 102.19K | $6.36M | — | Completed |
| Planned — Approximate Date | ||||
9/17/2026 | 8.28K | $525.7K | NASDAQ | Planned |
| Total | 283.19K | $17.84M | ||